Milestone: Creating Innovative Solutions Milestone Home
 
image thru microscope
Symposia Contact Home

CPSA Digest 2002

Emerging Standards for Drug Discovery and Development:
Perspectives on Technology, Strategy and Relationships

October 8-10, 2002

CPSA Digest 2002

Overview
Day 1: Proceedings | Plenary
Day 2: Proceedings
Day 3: Proceedings

CPSA 2002 Sponsors

CPSA Digest Archive
CPSA Digest 2000
CPSA Digest 2001
CPSA Digest 2002 >>
CPSA Digest 2003
CPSA Digest 2004


Proceedings

Day 3 - Thursday, October 10, 2002



ThOA
Data Management in a High-throughput Analysis Environment

Discussion Leader: Randall K. Julian, Eli Lilly & Company

Data Management in High-Throughput Mass Spectrometry I:
Automating Library and Result Processing Tasks

Eric B. Stauffer, Eli Lilly & Company

Data Management in High-Throughput Mass Spectrometry II:
Automated Spectral Analysis

Randall K. Julian, Eli Lilly & Company

Integration of Data Production, Processing and Visualization to Support High Throughput analysis of Intact Proteins

Greg Taylor, University of Illinois

Roundtable Discussion 7



ThOB
Why Does Method Development Take So Long?

Discussion Leader: Roger N. Hayes, Schering-Plough Reserach institute

The Changing Functionality of Pharmaceutical Compund Repositories

Brett Monia, ISIS Pharmaceuticals

Accelerating Method Development Using an Automated Modular Strategy and On-Line Turbulent Flow Chromatography

Russell Grant, Eli Lilly Canada, Inc.

Factors Effecting the Performance of Solid Phase Extraction in Conjunction with LC-MS/MS Analysis

Kenneth D. Roth, Schering-Plough Research Institute

High-Throughput Assay Validation in a GLP Laboratory

Preston P. Davis, Schering-Plough Research Institute

Roundtable Discussion 8



Poster Session Reviews

Discussion Leaders: Neil Loftus, Shimadzu Biotech, and Eric Solon, Quest Pharmaceutical Services



ThOC
In-Source, Out-Source:
What Do Pharmaceutical Companies Do for Bioanalytical Support?

Discussion Leader: Voon Ong, Memory Pharmaceuticals

Outsourcing Discovery: Obtaining Maximum Data With Minimum Proprietary Information Under Continuously Changing Experimental Requirements

Zamas Lam, Quest Pharmaceutical Services

Outsourcing Bioanalytical Support in Drug Discovery

Peter L. Bullock, Purdue Pharma

Outsourced Bioanalytical Projects

Tanya R. Myers, Solvay Pharmaceuticals

Roundtable Discussion 9



ThOD
Crystal City Guideline Review

Discussion Leader: Tom Huggins, Proctor & Gamble Pharmaceuticals

Al Yergey, National Institutes of Health
Bob Nicholson, PPD Development
Charles Grandmaison, MDS Pharma
Min Chang, Abbott Laboratories
Danlin Wu, Purdue Pharma


Wrap-Up

Kenneth L. Morand, Proctor & Gamble Pharmaceuticals



overview | training | workshops | consulting | symposia | contact | home